| |
Patient number (percentage of patients)
|
P value*
|
|---|
|
Total patient number
|
33
| |
|
Age(years)
| |
0.50
|
|
< 65
|
26(78.8)
| |
|
≥ 65
|
7 (21.2)
| |
|
Gender
| |
0.47
|
|
Male
|
24(72.7)
| |
|
Female
|
9(27.2)
| |
|
Location of primary tumor
| |
0.76
|
|
Colon
|
24(72.7)
| |
|
Rectum
|
9(27.2)
| |
|
Number of metastatic sites
| |
0.15
|
|
< 3
|
26(84.8)
| |
|
≥ 3
|
7(15.2)
| |
|
Liver metastases
| |
0.80
|
|
Yes
|
19(54.5)
| |
|
No
|
14(45.5)
| |
|
ECOG performance status
| |
0.007**
|
|
0 or 1
|
24(72.7)
| |
|
2
|
9(27.2)
| |
|
Histological type
| |
0.30
|
|
Adenocarcinoma
|
28(84.8)
| |
|
Mucinous
|
5(15.2)
| |
|
Previous chemotherapy treatment
| |
0.70
|
|
No
|
27 (81.8)
| |
|
Yes
|
6 (18.2)
| |
- *P value was calculated according to Cox proportional hazards model between PFS and the corresponding clinical information listed in the table
- **Significance was found between PFS and the ECOG performance
